Dobutamine Hydrochloride Injection shortage
Current 10 presentations · 3 manufacturers · first FDA posting 2017-11-06 · last update 2026-10-08
Manufacturers: Baxter Healthcare, Hainan Poly Pharm. Co., Ltd., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02) | Baxter Healthcare | Current Available |
— | Posted 11/06/2017 Updated 10/02/2026 | |
| Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02) | Baxter Healthcare | Current Available |
— | Posted 11/06/2017 Updated 10/02/2026 | |
| Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02) | Baxter Healthcare | Current Available |
— | Posted 11/06/2017 Updated 10/02/2026 | |
| Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80) | Hainan Poly Pharm. Co., Ltd. | Current Available |
— | Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988 | Posted 11/06/2017 Updated 09/16/2026 |
| Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 11/06/2017 Updated 10/08/2026 | |
| Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 11/06/2017 Updated 10/08/2026 | |
| Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 11/06/2017 Updated 10/08/2026 | |
| Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 11/06/2017 Updated 10/08/2026 | |
| Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 11/06/2017 Updated 10/08/2026 | |
| Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Posted 11/06/2017 Updated 10/08/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)